Skip to content

Routine Ultrasound Guidance for Vascular Access for Cardiac Procedures

Routine Ultrasound Guidance for Vascular Access for Cardiac Procedures: a Randomized Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03537118
Acronym
UNIVERSAL
Enrollment
621
Registered
2018-05-25
Start date
2018-06-20
Completion date
2022-07-15
Last updated
2022-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease, Myocardial Infarction, Myocardial Ischemia

Brief summary

A randomized, controlled trial to determine whether the use of ultrasound guidance for vascular access during coronary angiography or percutaneous coronary intervention (PCI) will reduce the rates of major vascular complications.

Detailed description

Patients who will undergo a coronary angiography or PCI using femoral access will be allocated to either: 1) femoral access using fluoroscopic and ultrasound guidance, or 2) femoral access using fluoroscopic guidance alone.

Interventions

PROCEDUREFluoroscopic + Ultrasound Guidance

Fluoroscopic Guidance Alone

Sponsors

Population Health Research Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Patient referred for coronary angiography or percutaneous coronary intervention (PCI) in whom femoral access is planned. 2. Planned femoral access

Exclusion criteria

1. Age ≤ 18 years 2. STEMI 3. Absence of palpable femoral pulse

Design outcomes

Primary

MeasureTime frameDescription
Incidence of major vascular complicationsup to 30 days post-procedureFemoral artery pseudoaneurysm, AV fistula, retroperitoneal bleed, large hematoma (\>5 cm), ischemic limb requiring intervention or surgery, or major bleed based on BARC II, III, or V criteria

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026